Authors: Darcissac, ECA Vidal, V Guillaume, M Thebault, JJ Bahr, GM

Citation: Eca. Darcissac et al., Clinical tolerance and profile of cytokine induction in healthy volunteersfollowing the simultaneous administration of IFN-alpha and the synthetic immunomodulator murabutide, J INTERF CY, 21(9), 2001, pp. 655-661

Authors: Bahr, GM Darcissac, ECA Casteran, N Amiel, C Cocude, C Truong, MJ Dewulf, J Capron, A Mouton, Y

Citation: Gm. Bahr et al., Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice, J VIROLOGY, 75(15), 2001, pp. 6941-6952

Authors: Vidal, VF Casteran, N Riendeau, CJ Kornfeld, H Darcissac, ECA Capron, A Bahr, GM

Citation: Vf. Vidal et al., Macrophage stimulation with murabutide, an HIV-suppressive muramyl peptidederivative, selectively activates extracellular signal-regulated kinases 1and 2, C/EBP beta and STAT1: role of CD14 and Toll-like receptors 2 and 4, EUR J IMMUN, 31(7), 2001, pp. 1962-1971

Authors: Darcissac, ECA Truong, MJ Dewulf, J Mouton, Y Capron, A Bahr, GM

Citation: Eca. Darcissac et al., The synthetic immunomodulator Murabutide controls human immunodeficiency virus type 1 replication at multiple levels in macrophages and dendritic cells, J VIROLOGY, 74(17), 2000, pp. 7794-7802

Authors: Truong, MJ Darcissac, ECA Hermann, E Dewulf, J Capron, A Bahr, GM

Citation: Mj. Truong et al., Interleukin-16 inhibits human immunodeficiency virus type 1 entry and replication in macrophages and in dendritic cells, J VIROLOGY, 73(8), 1999, pp. 7008-7013

Authors: Efremov, R Truong, MJ Darcissac, ECA Zeng, J Grau, O Vergoten, G Debard, C Capron, A Bahr, GM

Citation: R. Efremov et al., Human chemokine receptors CCR5, CCR3 and CCR2B share common polarity motifin the first extracellular loop with other human G-protein coupled receptors - Implications for HIV-1 coreceptor function, EUR J BIOCH, 263(3), 1999, pp. 746-756